Title here

Text here
 

Cancer Research Fund of the Damon Runyon - Walter Winchell Foundation Organization Name provided in the GuideStar Exchange* as of 12/13/2012: Cancer Research Fund of the Damon Runyon - Walter Winchell Foundation

Organization Name as listed in the IRS Business Master File as of 08/11/2014: CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION

* The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

AKA  Damon Runyon Cancer Research Foundation
New York, NY
GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

GuideStar Summary

&1002; GuideStar Exchange Committed to transparency ?
This organization is a Silver-level GuideStar Exchange participant, demonstrating its commitment to transparency.

Is this your nonprofit? Update your information today!
&1002; Registered with IRS Legitimacy information is available
&1002; Financial Data Annual Revenue and Expense data reported
&1002; Forms 990 2013, 2012, and 2011 Forms 990 filed with the IRS
&1002; Mission Objectives Mission Statement is available
&1002; Impact Summary Impact Summary from the nonprofit is available
  5 stars Average rating from 8 Personal Reviews | Write a Review

Basic Organization Information

Cancer Research Fund of the Damon Runyon - Walter Winchell Foundation Organization Name provided in the GuideStar Exchange* as of 12/13/2012: Cancer Research Fund of the Damon Runyon - Walter Winchell Foundation

Organization Name as listed in the IRS Business Master File as of 08/11/2014: CANCER RESEARCH FUND OF THE DAMON RUNYON-WALTER WINCHELL FOUNDATION

* The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
Also Known As: Damon Runyon Cancer Research Foundation
Physical Address: New York, NY 10006 
EIN: 13-1933825
Web URL: www.damonrunyon.org 
NTEE Category: H Medical Research
H30 Cancer Research
G Disease, Disorders, Medical Disciplines
G30 Cancer
H Medical Research
H12 Fund Raising and/or Fund Distribution
Ruling Year: 1947 


Sign in or create an account to see this organization's full address, contact information, and more!

Mission Statement

To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. We strive to: > Identify the best and brightest young scientists in cancer research. > Accelerate the translation of scientific discoveries into new diagnostic tools and treatments. > Enable risk-taking on bold new ideas.

Legitimacy Information

This organization is registered with the IRS.

This organization is required to file an IRS Form 990 or 990-EZ.

Institutional funders should note that an organization’s inclusion on GuideStar.org does not satisfy IRS Rev. Proc. 2011-33 for identifying supporting organizations.

Learn more about GuideStar Charity Check, the only pre-grant due diligence tool that is 100% compliant with IRS Rev. Proc 2011-33.

GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Annual Revenue & Expenses

(GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
December 2012)

Fiscal Year Starting: July 1, 2010
Fiscal Year Ending: June 30, 2011

Total Revenue $15,110,764
Total Expenses $14,877,809

Revenue & Expenses

(GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
December 2012)

Fiscal Year Starting: July 1, 2010
Fiscal Year Ending: June 30, 2011

Sign in or create an account to view this information from the GuideStar Exchange

The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Chart Illustration Revenue and Expense data from Forms 990 for 2013, 2012, 2011, 2010, 2009 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Back to Top »

Balance Sheet (IRS Form 990)

Chart Illustration Balance Sheet data from Forms 990 for Year 2013, 2012, 2011, 2010, 2009 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Back to Top »
GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Forms 990 Received from the IRS Additional Information
IRS Form 990 is an annual document used by approximately one-third of all public charities to report information about their finances and operations to the federal government. GuideStar uses data from Form 990 to populate its database with financial information about nonprofit organizations. Posting Form 990 images on the GuideStar website is an ongoing process.

Sign in or create an account to view Form(s) 990 for 2013, 2012, 2011.

Chart Illustration Forms 990 for 2013, 2012, 2011, 2010, 2009 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Forms 990 Provided by the Nonprofit

Sign in or create an account to view Form(s) 990 for 2011, 2010, 2009.

Financial Statements

Chart Illustration Financial Statements for 2011, 2010, 2009 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Annual Reports

Sign in or create an account to view this information.

GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Leadership

(GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
December 2012)

Lorraine W. Egan

Term:

Since July 2000

Profile:

Lorraine W. Egan, Executive Director, received a B.A. from Tufts University and a J.D. from the University of Chicago Law School. She was a health care and litigation attorney at Ropes and Gray in Boston before joining Mount Sinai Medical Center in New York as Associate General Counsel. Prior to joining the Foundation, she was Vice President and Assistant to the President at Mount Sinai NYU Health.

Leadership Statement:

In 2013, we face a significant risk of losing this generation’s best young scientists to other careers. They are being forced out of research due to limited funding opportunities, the bias of most funders toward incremental research, and the drawn out nature of research training. At Damon Runyon, we believe this is unacceptable. Today, smart people in their twenties and thirties are changing our world, from Google to Facebook. We want young geniuses to be focused on beating cancer. They are our best hope. As a Damon Runyon supporter, you know that funding today’s best young scientists works. We have funded thousands of researchers in the past 65 years whose breakthroughs have saved countless lives. You can see current and past achievements by visiting our Research and Results pages(http://www.damonrunyon.org/research_results/) . We deeply appreciate your support. If you choose to give to Damon Runyon, the discoveries of our scientists become your legacy. As always, 100% of your donation will directly support a Damon Runyon scientist. (Our overhead is paid from Damon Runyon Broadway Tickets and our endowment.) Your help is needed today as urgently as ever to stem the flow of our best young minds to other professions, and to keep them focused on making new breakthroughs against cancer. Best wishes for a happy and healthy 2013. Sincerely, Lorraine W. Egan Executive Director 100% of your donation will directly support a Damon Runyon scientist.  (Our overhead is paid from Damon Runyon Broadway Tickets(http://www.damonrunyon.org/broadway) and our endowment.)

Board Chair (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
December 2012)

Sign in or create an account to view this information from the GuideStar Exchange

Board Co-Chair

This information has not been provided by the nonprofit. Click here if you are associated with this organization and want to provide this information.

Board of Directors (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
December 2012)

Sign in or create an account to view this information from the GuideStar Exchange

Board Leadership Practices (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
December 2012)
?

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section, which enables organizations and donors to transparently share information about essential board leadership practices.

Board Orientation & Education ?
Why does this matter? Without clarity around their responsibilities and expectations, board members are not positioned to succeed. They may find themselves challenged to fulfill their governance responsibilities or frustrated by the expectations that the organization has set for them. BoardSource recommends that every new board member participate in a formal orientation process, and that all board members sign a pledge or agreement committing to their board service and to all of the responsibilities and expectations that come with service. Ideally, board members also should participate in a formal governance training program prior to serving on a board.

Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations?
Response Not Provided
CEO Oversight ?
Why does this matter? Oversight and management of the chief executive is one of the board’s most important legal responsibilities. The CEO or executive director is the board's single employee, and - just like any other employer/employee relationship - regular and written assessment is critical to ensuring that the chief executive and board are communicating openly about goals and performance. BoardSource recommends that boards conduct formal, written reviews of their chief executives on an annual basis, which should include an in-person discussion with the chief executive and distribution of the written evaluation to the full board.

Has the board conducted a formal, written assessment of the chief executive within the past year?
Response Not Provided
Ethics & Transparency ?
Why does this matter? A commitment to handling conflicts of interests is essential to creating an organizational culture of transparency. Boards should create and follow a policy for identifying and handling conflicts of interest, whether real or perceived. BoardSource recommends that organizations review the conflict-of-interest statement and require signed disclosures from all board members and senior staff on an annual basis.

Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements within the past year?
Response Not Provided
Board Composition ?
Why does this matter? The best boards are composed of individuals who bring a variety of skills, perspectives, backgrounds, and resources to tackle the complex and strategic challenges confronting their organizations. BoardSource recommends that boards commit to diversity and inclusion by establishing written policies and practices, which include strategic and intentional recruitment of diverse board members, continual commitment to inclusivity, and equal access to board leadership opportunities.

Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership?
Response Not Provided
Board Performance ?
Why does this matter? Boards need to regularly assess their own performance. Doing so ensures that they are being intentional about how they govern their organization, which is a critical component of effective board leadership. BoardSource recommends that a board conduct a self-assessment of its performance a minimum of once every three years to ensure that it is staying on track with its roles and responsibilities.

Has the board conducted a formal, written self-assessment of its performance within the past three years?
Response Not Provided

Officers for Fiscal Year (IRS Form 990)

Chart Illustration Officers for 2013, 2012, 2011, 2010, 2009 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

Highest Paid Employees & Their Compensation (IRS Form 990)

Chart Illustration Highest Paid Employee Data for 2013, 2012, 2011, 2010 are included in the GuideStar Premium Report. Upgrade Now Report Added To Cart

People information was last updated by the nonprofit in December 2012

Click here if you are associated with this organization and want to provide updated information.

GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Programs

Program: Program Overview (GuideStar Exchange,
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.
December 2012)

Budget:
$10,125,000
Category:
Medical Research
Population Served:
Other Named Groups

Program Description:

We offer four programs aimed at encouraging and advancing the work of early career cancer researchers with high promise.  Each program is designed to address a need or fill a gap in cancer research funding. Our grant-making process is rigorous and highly competitive.  Each program is overseen by a separate committee of renowned scientists(http://www.damonrunyon.org/for_scientists/more/award_committees) who select our award recipients. Damon Runyon Fellowship Award The Damon Runyon Fellowship Award is the Foundation’s oldest and most well recognized award.  It is one of the highest accolades an early career scientist can receive.  The grant is designed to give the nation's top minds the resources to further hone their cancer research skills and explore their own innovative ideas, while working with mentors in top universities and cancer research centers. The Damon Runyon Fellowship Award is the scientist’s primary source of funding for three years—$156,000 for PhDs and $186,000 for MDs.  Your support(http://www.damonrunyon.org/donate) allows us to fund the cancer research projects of approximately 30 new Fellows each year. At the end of the Fellowship, there are often a select few Damon Runyon Fellows who have greatly exceeded the Foundation’s highest expectations.  To catapult their research careers—and their impact on cancer—the Foundation will make an additional investment in these exceptional individuals by selecting them as recipients of the Dale F. Frey Award for Breakthrough Scientists. Damon Runyon Clinical Investigator Award The Damon Runyon Clinical Investigator Award was launched in 2000 to help speed the process of moving laboratory discoveries to the patient bedside.  It is designed to support and encourage physicians committed to translating cancer treatment research into cures, helping to address a national shortage of these specially trained scientists. The Damon Runyon Clinical Investigator Award provides $450,000 over three years to each recipient for salary, research and staffing expenses.  To address one reason for the decline of physician-scientists, the Foundation will also pay up to $100,000 of recipients’ medical school debt.  Thanks to your support(http://www.damonrunyon.org/donate) , Damon Runyon is currently funding 23 Clinical Investigators. Continuation Grants(http://www.damonrunyon.org/for_scientists/more/clinical_investigator_award_continuation_grant) All third-year Damon Runyon Clinical Investigators are eligible to apply for the Damon Runyon Clinical Investigator Award Continuation Grant, which is designed to provide two additional years of support to Damon Runyon Clinical Investigators who are approaching the end of their awards and need extra time and funding to complete a promising avenue of research, or initiate/continue a clinical trial.  Damon Runyon-Rachleff Innovation Award The new ideas and fresh perspectives of early career scientists often lead to breakthroughs.  Yet the largest funder of biomedical research in this county, the federal government, is notoriously conservative, requiring that successful investigators show extensive preliminary data that essentially proves that their proposed research will succeed.  As a result, bold, risky ideas remain on the shelf. Recognizing this paradox, venture capitalist Andy Rachleff, with his wife Debbie, combined forces with the Damon Runyon Cancer Research Foundation to create the Damon Runyon-Rachleff Innovation Award.  The Award funds cancer research by exceptionally creative thinkers with “high-risk/high-reward” ideas—ideas that have the potential to significantly impact cancer, but lack sufficient preliminary data to obtain traditional funding. The Innovation Award provides a total of $450,000 over a three-year period for salary and cancer research expenses.  In its first year, the Award attracted more than 400 applicants from top scientists across the US, highlighting the urgent need for this award.  Damon Runyon-Sohn Pediatric Cancer Fellowship Award  Launched in 2012, the Damon Runyon-Sohn Pediatric Cancer Fellowship Award provides funding to basic scientists and clinicians who conduct research with the potential to significantly impact the prevention, diagnosis or treatment of one or more pediatric cancers. The goal of this new Fellowship Award is to recruit the top young minds to research childhood cancers. It leverages the success of the internationally-renowned Damon Runyon Fellowship Award(http://www.damonrunyon.org/research_results/categories/category/award_programs/) , which has an unparalleled track record for identifying future breakthrough scientists. After a national call for proposals, a selection committee chaired by William Carroll, MD, Director of the New York University Cancer Institute and comprised of leaders in pediatric cancer research, will select award recipients.  The program is being launched as a pilot project with the potential for expansion if successful.

Program Long-Term Success:

Program Short-Term Success:

Program Success Monitored by:

Program Success Examples:

Since 1946, Damon Runyon scientists, including 11 Nobel Laureates, have made some of the most important discoveries in cancer research, including: Groundbreaking research confirming the link between cigarette smoking and lung cancer (1954) Identification of the first cancer-causing gene (1970) Development of treatments to arm the immune system against cancer cells (2008) A timeline of more achievements is available on our website at http://www.damonrunyon.org
GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Impact Summary from the Nonprofit

Since 1946, Damon Runyon scientists, including 11 Nobel Laureates, have made some of the most important discoveries in cancer research, including: Groundbreaking research confirming the link between cigarette smoking and lung cancer (1954) Identification of the first cancer-causing gene (1970) Arming the immune system to successfully treat late stage melanoma (2008) Development of Yervoy, a life-extending immunotherapy for metastatic melanoma (2011) View an interactive timeline(http://www.damonrunyon.org/research_results/timeline_of_results/) of our achievements and milestones over the last 60+ years.
GuideStar Exchange - Silver Participant What is this?
The GuideStar Exchange allows nonprofits to regularly update key information directly to GuideStar. It provides richer and broader information about their programs, impact, finances, people and more.

Reviews

Organization Data Available

Adobe PDF Format A GuideStar Premium Report in PDF format is available for this organization

Price for this Report: $125.00

This Premium Report includes:

  • Financial Data for
  • Financial Charts for
  • Forms 990 for
  • Forms 990T for
  • Audited Financial Statement for
  • Annual Reports for
  • Letter of Determination
  • Form 1023 / 1024
  • Board Members
  • Officer, Director and/or Highest Paid Employee data for


Learn more about GuideStar Premium